News

Biotech company wins $4.4M Defense Department award to develop dengue vaccine | Health IT

By August 17, 2022No Comments

Biotechnology company Codagenix has been awarded $4.4 million from the Defense Department to continue the development of a dengue vaccine.Health IT

Leave a Reply Cancel Reply

The Washington Metropolitan Area Chapter(WMAC) of the National Association of Health Services Executives (NAHSE) was chartered in 1978 to educate and develop minority healthcare leaders while, in conjunction with the American College of Healthcare Executives (ACHE), promoting C-Suite diversity for Healthcare Organizations throughout Northern Virginia, Southern Maryland, and the District of Columbia. The Washington Metropolitan Area Chapter (WMAC) was one of the first two chapters founded by the Association, since its inception.

Biotech company wins $4.4M Defense Department award to develop dengue vaccine | Health IT

Tags:

Previous PostIncredible Health reaches $1.65B valuation | Health IT

Next PostWhere innovation is needed most in healthcare | Health IT

Leave a Reply Cancel Reply

Join the NAHSE-WMAC Mailing List

Contact Us